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Acute kidney injury
Acute kidney injury (AKI) is an abrupt 
decline in kidney function that occurs 
over a few hours or a few days, is com-
mon in people who are already hospital-
ized, and is associated with significant 
morbidity and mortality. Multiple factors 
predispose to development of AKI, and 
treatment options, other than support-
ive interventions, are few (1). In addi-
tion to being associated with ischemic 
injury and sepsis, AKI can also result 
from the toxicity of therapeutic agents, 
such as aminoglycoside antibiotics or 
cisplatin chemotherapy. New work from 
Lau et al. in this issue of the JCI (2) exam-
ines the mechanism of contrast-induced 
AKI (CI-AKI), a form of AKI observed in 
patients receiving intravascular iodinated 
contrast media for diagnostic imaging 
studies. While the risk associated with the 
use of contrast media is a matter of current 
debate (3, 4), there is clear evidence for 
injury resulting from contrast administra-
tion in both animal models and humans, 
especially in patients with risk factors such 
as underlying chronic kidney disease. The 
mechanism described by Lau and col-
leagues is notable for the involvement 
of multiple cell types, including tubular 
epithelial cells and both resident and 
circulating leukocytes, all of which are 
required for the development of CI-AKI. 
This is consistent with emerging multifac-
torial paradigms for the development of 
AKI from various causes (5) and suggests 
both opportunities and challenges for the 
development of rationally designed thera-
peutic interventions.
Animal models to study 
pathophysiology of CI-AKI
A major challenge in studies of AKI has 
been the applicability of animal models of 
AKI to what is observed in patients (6). Lau 
et al. use a mouse model of contrast agent 
administered to volume-depleted animals, 
chosen since volume depletion has been 
well documented as a contributing factor 
to the development of CI-AKI (7). This is 
clearly not a perfect model, since it (or 
any animal model, for that matter) cannot 
include all the complex and variable comor-
bidities, such as underlying cardiovascu-
lar disease, that are inevitable in patients 
referred for imaging studies. Nevertheless, 
there is some reassurance to be drawn from 
their inclusion of data from a prospective 
study of a small cohort of patients under-
going coronary angiography that are con-
sistent with the mechanisms shown to be 
active in the mouse experiments.
A variety of explanations have been 
invoked to account for the pathophysiol-
ogy of CI-AKI, with proposed mechanisms 
involving physiological changes such as 
medullary ischemia, high levels of reactive 
oxygen species, and toxicity of contrast 
media when taken up by tubular epithe-
lial cells (8). Although related factors are 
also implicated in AKI from other causes, 
the broad AKI field has also embraced the 
idea that inflammatory processes induced 
by inappropriately exuberant activation 
of immune responses are major contribu-
tors, and that both resident and infiltrat-
ing leukocytes are involved (5). Lau et al. 
show that this paradigm extends to CI-AKI 
and, in so doing, show that immune acti-
vation happens in distinct compartments 
and depends on uptake of contrast both by 
tubular epithelial cells and by resident and 
infiltrating phagocytes.
Mechanism of contrast-induced 
immune activation
Their first challenge was to identify a 
plausible molecular mechanism by which 
contrast might cause immune activa-
tion. Inflammasomes are multisubunit 
complexes that are now recognized to 
be important players in both infection 
and the pathological inflammation that 
characterizes diabetes, cardiovascular 
disease, cancer, and a number of kidney 
diseases. Inflammasomes induce inflam-
matory responses or cell death by bring-
ing together activator molecules capable 
of sensing a variety of danger signals such 
as pathogens that have invaded a cell, or 
danger-associated molecular patterns 
(DAMPs) released from dead or dying 
cells, together with effector proteases of 
the caspase family (9). One such inflam-
masome activator, Nod-like receptor pyrin 
containing 3 (Nlrp3), responds to a variety 
of stimuli, including ATP, alterations in 
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Acute kidney injury comprises a heterogeneous group of conditions 
characterized by a sudden decrease in renal function over hours to days. 
Contrast-induced acute kidney injury (CI-AKI) is caused by radiographic 
contrast agents used in diagnostic imaging. In the current issue of the JCI, Lau 
et al. use a mouse model of CI-AKI to study the role of resident and infiltrating 
phagocytes, recruited leukocytes, and tubular cells in the immune surveillance 
response to contrast agents. This study has the potential to provide innovative 
therapies for human CI-AKI.
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Nlrp3 inflammasome–dependent canon-
ical pathways. Reabsorption of contrast 
from the tubule and its delivery to the 
interstitium is necessary for its uptake by 
infiltrating leukocytes, and so the tubu-
lar epithelial cells, by taking up contrast 
that has accumulated in the tubule, retain 
their starring role in the CI-AKI injury 
mechanism. Lau et al. showed that inter-
fering with the ability of the tubular cells 
to internalize contrast is a potential point 
of therapeutic intervention that can block 
immune activation and the resulting pro-
gression to CI-AKI.
Lessons from the study
There are several noteworthy outcomes of 
this study. First, there are three essential 
steps in the onset of CI-AKI: activation of 
the Nlrp3 inflammasome in the kidney’s 
resident leukocytes, tubular accumulation 
and reabsorption of contrast, and, finally, 
recruitment of infiltrating leukocytes 
and activation of their Nlrp3-dependent 
canonical signaling. This suggests that 
there has been some selection against 
inappropriate activation of these inflam-
matory mechanisms. Another important 
outcome is the clear mechanistic explana-
tion for the contribution of volume status 
to the likelihood of AKI in patients receiv-
ing contrast. Volume depletion is neces-
sary for the tubular accumulation and 
reabsorption, since it allows activation of 
infiltrating leukocytes, and is therefore 
necessary for progression to CI-AKI. A 
processes to be followed in a live animal 
(11). In this study, the distribution of a 
fluorescently labeled contrast agent was 
traced by intravital microscopy, showing 
that the agent was present in peritubular 
capillaries and was filtered in the glom-
erulus, appearing in the lumen of the kid-
ney tubules, regardless of volume status. 
Moreover, resident renal phagocytes, 
components of the kidney’s intrinsic 
immune surveillance mechanism, were 
seen to internalize the contrast agent and 
demonstrated activation of the canoni-
cal pathways downstream of the Nlrp3 
inflammasome. However, the accumu-
lation of contrast in the tubule lumen 
and the dynamics of infiltrating leuko-
cytes were markedly different depend-
ing on the volume status of the animals 
(Figure 1). In well-hydrated mice (not 
susceptible to CI-AKI), the contrast was 
rapidly cleared from the tubule lumen, 
whereas in volume-depleted animals 
(susceptible to CI-AKI), contrast tended 
to accumulate in patches in the tubule, 
with evidence of reabsorption. An Nlrp3- 
dependent influx of leukocytes coincided 
with the accumulation and reabsorp-
tion of contrast, suggesting that this is 
an essential trigger of immune activa-
tion leading to CI-AKI. Indeed, infiltrat-
ing leukocytes were seen to crawl over 
the epithelial cells in the tubular regions 
where contrast accumulated, and these 
infiltrating leukocytes also showed inter-
nalization of contrast and activation of 
intracellular potassium, and particulate 
matter, and has previously been shown 
to be an immune activator in kidney dis-
eases (see, for example, ref. 10). Among 
the downstream effects induced by Nlrp3 
inflammasomes is caspase-1–dependent 
activation of IL-1β via the so-called canon-
ical pathway; noncanonical pathways acti-
vate various forms of cell death, including 
apoptosis. Lau et al. showed that this is also 
the case in their mouse model: volume- 
depleted Nlrp3–/– mice were protected 
against the injury induced by contrast in 
their Nlrp3+/+ counterparts. But in what 
cells does Nlrp3 inflammasome activa-
tion trigger the initiation of the injury pro-
cess? Although contrast media have been 
shown to have direct toxic effects on tubu-
lar epithelial cells, and the Nlrp3 inflam-
masome is able to induce apoptosis via a 
noncanonical pathway, Nlrp3-dependent 
apoptosis alone did not account for the 
cytotoxic effects of contrast media seen in 
cell culture, and CI-AKI did not result from 
Nlrp3-dependent mechanisms in trinsic to 
the epithelial cells alone. However, con-
trast agent strongly activated the Nlrp3 
inflammasome in leukocytes, producing 
IL-1β activation.
Live imaging of 
pathophysiological processes 
using intravital microscopy
Intravital microscopy is a powerful tech-
nique that allows the spatial dynamics 
of physiological and pathophysiological 
Figure 1. Dependence of contrast distribution and immune activation on volume status. In the hydrated state (A), contrast is filtered and passes into the 
tubule lumen but does not accumulate and is not reabsorbed. Consequently, the inflammasome in infiltrating leukocytes is not stimulated, and there is 
insufficient immune activation to induce a prolific leukocyte infiltration and strong inflammatory response. In contrast (B), in the volume-depleted state, 
filtered contrast accumulates in the tubule lumen and is reabsorbed, resulting in stimulation of infiltrating leukocytes in addition to resident macrophages, 
leading to a massive influx of leukocytes and an excessive inflammatory response that ultimately precipitates AKI. DPEP-1, dipeptidase-1.
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caveat is that this apparently finely regu-
lated system may well behave differently 
in patients with the comorbidities that are 
common in those who are candidates for 
imaging studies, particularly when these 
comorbid conditions involve the devel-
opment of a sterile inflammatory disease 
state. This may compromise the effec-
tiveness of treatment interventions such 
as blocking contrast uptake by tubular 
epithelial cells using dipeptidase-1 inhibi-
tors, as employed by Lau et al. Finally, this 
study shows that the underlying mecha-
nisms of CI-AKI revolve around dys-
regulated inflammatory responses in the 
kidney and thus are consistent with the 
prevailing thinking on other forms of AKI, 
perhaps suggesting that there are pros-
pects for new therapeutic approaches that 
will be effective in AKI broadly.
